Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients (Q35906322)

11 August 2017

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients (English)

1 reference

11 August 2017

7

Hiroji Iwata

1 reference

11 August 2017

Tatsuya Toyama

1

1 reference

11 August 2017

Zhenhuan Zhang

2

1 reference

11 August 2017

Mariko Nishio

3

1 reference

11 August 2017

Maho Hamaguchi

4

1 reference

11 August 2017

Naoto Kondo

5

1 reference

11 August 2017

Hirotaka Iwase

6

1 reference

11 August 2017

Satoru Takahashi

8

1 reference

11 August 2017

Hiroko Yamashita

9

1 reference

11 August 2017

Yoshitaka Fujii

10

1 reference

11 August 2017

1 January 2007

1 reference

11 August 2017

Breast Cancer Research

1 reference

11 August 2017

9

1 reference

11 August 2017

R34

1 reference

11 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr1682

11 August 2017

0 references

cites work

A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Repeated observation of breast tumor subtypes in independent gene expression data sets

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

The p53-Mdm2 module and the ubiquitin system.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

11 July 2018

Surfing the p53 network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Two polymorphic variants of wild-type p53 differ biochemically and biologically

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

p53, the cellular gatekeeper for growth and division

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Primary structure polymorphism at amino acid residue 72 of human p53.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.

11 July 2018

1 reference

Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients.

21 January 2018

1 reference

p53 polymorphic variants at codon 72 exert different effects on cell cycle progression

21 January 2018

1 reference

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer

21 January 2018

1 reference

p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients.

21 January 2018

1 reference

p53 polymorphisms and haplotypes in breast cancer.

21 January 2018

1 reference

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

21 January 2018

1 reference

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

21 January 2018

1 reference

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

21 January 2018

1 reference

TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

21 January 2018

1 reference

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

21 January 2018

1 reference

p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis.

21 January 2018

1 reference

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1929098

p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome

24 September 2018

1 reference

Association of breast cancer outcome with status of p53 and MDM2 SNP309

21 January 2018

1 reference

12 December 2020

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas

1 reference

12 December 2020

p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma

1 reference

12 December 2020

Abnormal expression of MDM-2 in breast carcinomas

1 reference

12 December 2020

Genotype phenotype correlations in Israeli colorectal cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR1682

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference